Literature DB >> 2895352

Follow-up of neuropathy from 2',3'-dideoxycytidine.

R M Dubinsky, M Dalakas, R Yarchoan, S Broder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2895352     DOI： 10.1016/s0140-6736(88)91697-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  In vitro and in vivo evidence that the antiviral activity of 2',3'-dideoxycytidine is target cell dependent in a feline retrovirus animal model.

Authors:  P J Polas; C L Swenson; R Sams; C M Cheney; K A Hayes; M J Tarr; G J Kociba; L E Mathes
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

Review 2.  Clinical pharmacology of zidovudine and other 2',3'-dideoxynucleoside analogues.

Authors:  F Kamali
Journal:  Clin Investig       Date:  1993-05

Review 3.  Antiviral therapy in human immunodeficiency virus infection.

Authors:  E Sandström
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.